These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
176 related items for PubMed ID: 3023565
21. Evaluation of residual renal function and prediction of the prognosis of polycystic kidney disease by 99m Tc-dimercaptosuccinic acid (DMSA) renal scintigraphy. Kawamura J, Yoshida O. Nihon Jinzo Gakkai Shi; 1981 Jul; 23(7):1031-4. PubMed ID: 6275152 [No Abstract] [Full Text] [Related]
22. Myocardial infarct imaging in patients with technetium-99m 2,3-dimercaptosuccinic acid. Superiority of technetium-99m pyrophosphate. Lyons KP, Milne N, Karlsberg RP, Olson HG, Kuperus J. Clin Nucl Med; 1987 Jul; 12(7):514-8. PubMed ID: 3038447 [Abstract] [Full Text] [Related]
23. A convenient method for the preparation of 99mTc(V)dimercaptosuccinic acid (99mTc(V)-DMSA). Westera G, Gadze A, Horst W. Int J Appl Radiat Isot; 1985 Apr; 36(4):311-2. PubMed ID: 2991143 [Abstract] [Full Text] [Related]
25. Two routes for 99mTc-DMSA uptake into the renal cortical tubular cell. Peters AM, Jones DH, Evans K, Gordon I. Eur J Nucl Med; 1988 Sep; 14(11):555-61. PubMed ID: 2850186 [Abstract] [Full Text] [Related]
26. A comparison of the tumor-seeking agent Tc-99m(V) dimercaptosuccinic acid and the renal imaging agent Tc-99m dimercaptosuccinic acid in humans. Ohta H, Ishii M, Yoshizumi M, Endo K, Sakahara H, Nakajima T, Yomoda I, Masuda H, Horiuchi K, Hata N. Clin Nucl Med; 1985 Mar; 10(3):167-70. PubMed ID: 2985320 [Abstract] [Full Text] [Related]
27. The quantitation of 99Tcm-DMSA in paediatrics. Gordon I, Evans K, Peters AM, Kelly J, Morales BN, Goldraich N, Yau A. Nucl Med Commun; 1987 Aug; 8(8):661-70. PubMed ID: 2827079 [No Abstract] [Full Text] [Related]
28. Use of Tc-99m DMSA and Tc-99m DTPA in reflux. Gordon I. Semin Urol; 1986 May; 4(2):99-107. PubMed ID: 3012742 [No Abstract] [Full Text] [Related]
29. Evaluation of 99mTc-dimercaptosuccinic acid renal uptake as an index of individual kidney function after acute ureteral obstruction and desobstruction. An experimental study in rats. Schelfhout W, Simons M, Oosterlinck W, De Sy WA. Eur Urol; 1983 May; 9(4):221-6. PubMed ID: 6307703 [Abstract] [Full Text] [Related]
30. Clinical evaluation of 99mTc-DMSA renogram. Van Poppel H, Vereecken R, Vekemans K, Verduyn H, Mortelmans L, de Roo M. Urology; 1985 Apr; 25(4):413-7. PubMed ID: 2984825 [Abstract] [Full Text] [Related]
31. [Radioisotopic quantification of kidney function using Tc-99m-DMSA. Comparison with creatinine clearance in children with a single kidney]. Baillet G, Gagnadoux MF, Mathonnat F, de Vernejoul P, Broyer M. Nephrologie; 1986 Apr; 7(4):143-5. PubMed ID: 3025756 [Abstract] [Full Text] [Related]
32. Optimal handling of dimercaptosuccinic acid for quantitative renal scanning. Taylor A, Lallone RL, Hagan PL. J Nucl Med; 1980 Dec; 21(12):1190-3. PubMed ID: 6255114 [Abstract] [Full Text] [Related]
33. Poor technetium-99m-dimercaptosuccinic acid renal uptake and tubulointerstitial disease of the kidney. Piers DA, van Luijk WH. J Nucl Med; 1993 Feb; 34(2):354. PubMed ID: 8381476 [No Abstract] [Full Text] [Related]
34. Mechanism of renal concentration of technetium-99m glucoheptonate. Lee HB, Blaufox MD. J Nucl Med; 1985 Nov; 26(11):1308-13. PubMed ID: 2997418 [Abstract] [Full Text] [Related]
35. Can technetium-99m-mercaptoacetyltriglycine replace technetium-99m-dimercaptosuccinic acid in the exclusion of a focal renal defect? Gordon I, Anderson PJ, Lythgoe MF, Orton M. J Nucl Med; 1992 Dec; 33(12):2090-3. PubMed ID: 1334134 [Abstract] [Full Text] [Related]
36. Renal uptake of 99mTc-dimercaptosuccinic acid is dependent on normal proximal tubule receptor-mediated endocytosis. Weyer K, Nielsen R, Petersen SV, Christensen EI, Rehling M, Birn H. J Nucl Med; 2013 Jan; 54(1):159-65. PubMed ID: 23232279 [Abstract] [Full Text] [Related]
37. Poor renal uptake of Tc-99m DMSA and Tc-99m MDP in a patient with Fanconi syndrome and near normal glomerular filtration rate. Kim SE, Cho JT, Lee DS, Chung JK, Kim S, Lee MC, Lee JS, Koh CS. Clin Nucl Med; 1995 Mar; 20(3):215-9. PubMed ID: 7750213 [Abstract] [Full Text] [Related]
38. 2,3-Dimercaptosuccinic-acid chelates--1. Structure and pharmacokinetic studies. Moretti JL, Rapin JR, Saccavini JC, Lageron A, Le Poncin M, Bardy A. Int J Nucl Med Biol; 1984 Mar; 11(3-4):270-4. PubMed ID: 6099340 [No Abstract] [Full Text] [Related]
39. [Nuclear medicine kidney diagnosis in progressive systemic scleroderma]. Ammari B, Hotze A, Biltz H, Grünwald F, Küster W, Biersack HJ, Kreysel HW. Hautarzt; 1991 Oct; 42(10):627-30. PubMed ID: 1661715 [Abstract] [Full Text] [Related]
40. A clinical study of the prognostic value of technetium dimercaptosuccinic Acid uptake in renal obstruction. de Meyer JM, Oosterlinck W, Simons M, Schelfhout W, De Sy WA. Acta Urol Belg; 1986 Oct; 54(2):137-42. PubMed ID: 3014847 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]